Clearmind Medicine CMND
NASDAQ CMND
$1.73 -0.15 (-7.98%)
At close: Aug 20, 2026 · 4:00 PM EDT

Clearmind Medicine (CMND) Revenue (2024)

Clearmind Medicine (CMND) posted quarterly Revenue of -$18793.0 for Q3 2024.

Clearmind Medicine (CMND) Revenue (2024) Analysis & Trends

Clearmind Medicine's Revenue history runs 1 years deep, the most recent figure standing at -$18793.0 for Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.52 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.29 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 425.49 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 674.14 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 1.06 Bn
10 Clearmind Medicine 520,887.91 -13.07 Mn - -

Historic Data

Download Data
DateValue
Jul 31, 2024 -18,793.00